Related Experiment Video
Updated: May 5, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Comprehensive safety assessment of Pediococcus acidilactici SY23 for potential probiotic use in inflammation
Soobin Park1, Huijin Jeong1, Na-Kyoung Lee2
1Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120 Republic of Korea.
Abstract:
A comprehensive safety evaluation of P. acidilactici SY23 was conducted to assess its suitability as a probiotic strain with anti-inflammatory potential. Previous studies have reported anti-inflammatory activity of P. acidilactici SY23 in RAW 264.7 cells. In the present study, P. acidilactici SY23 exhibited no mucin degradation, gelatin liquefaction, urease or β-glucuronidase activity, or bile salt deconjugation. Biogenic amines and indoles were not detected, whereas D-lactate was produced at approximately 47 mM under the tested conditions. P. acidilactici SY23 also showed no β-hemolytic activity and no cytotoxicity toward Caco-2 cells. Antibiotic susceptibility testing showed that the minimum inhibitory concentrations were below EFSA cut-off values for all tested antibiotics. Whole-genome analysis further confirmed the absence of acquired antibiotic resistance and virulence genes. Collectively, these findings suggest that P. acidilactici SY23 may be a suitable probiotic candidate under the evaluated conditions.
Supplementary Information:
The online version contains supplementary material available at 10.1007/s10068-026-02134-8.
Insights
Lactobacillus acidilactici SY23 was evaluated for probiotic safety. It demonstrated no harmful activities and possessed antibiotic susceptibility, suggesting its suitability as a safe probiotic candidate.
Area of Science:
- Microbiology
- Probiotics
- Food Safety
Background:
- Previous research indicated anti-inflammatory properties of Lactobacillus acidilactici SY23 in cell models.
- A thorough safety assessment is crucial for probiotic strain validation.
Purpose of the Study:
- To comprehensively evaluate the safety of Lactobacillus acidilactici SY23 for probiotic applications.
- To confirm its suitability as a potential anti-inflammatory probiotic.
Main Methods:
- In vitro assays for mucin degradation, gelatin liquefaction, urease, beta-glucuronidase, and bile salt deconjugation.
- Analysis of biogenic amines, indoles, D-lactate production, beta-hemolytic activity, and cytotoxicity.
- Antibiotic susceptibility testing and whole-genome sequencing.
Main Results:
- Lactobacillus acidilactici SY23 showed no undesirable enzymatic activities or biogenic amine production.
- No cytotoxicity or beta-hemolytic activity was observed. D-lactate was produced at ~47 mM.
- All tested antibiotics showed minimum inhibitory concentrations below European Food Safety Authority (EFSA) cut-off values, with no acquired resistance genes detected.
Conclusions:
- Lactobacillus acidilactici SY23 exhibited a favorable safety profile in vitro.
- The absence of virulence factors and antibiotic resistance genes supports its probiotic potential.
- Lactobacillus acidilactici SY23 is a promising candidate for probiotic development.
Related Concept Videos
Probiotics
Clinical Significance of Antibiotic Resistance
Microbes in the Production of Fermented Foods

